Good evening :)
Place Order
Add to Watchlist

Bharat Immunologicals and Biologicals Corporation Ltd

BIBCL

Bharat Immunologicals and Biologicals Corporation Ltd

BIBCL
Health CarePharmaceuticals
SmallcapWith a market cap of ₹111 cr, stock is ranked 2,953
High RiskStock is 3.94x as volatile as Nifty
25.980.31% (+0.08)
25.980.31% (+0.08)

Price Chart

High
Low
Returns
1D
1W
1M
1Y
5Y
Max
SIP
Loading...
1D
1W
1M
1Y
5Y
Max
SIP
Health CarePharmaceuticals
SmallcapWith a market cap of ₹111 cr, stock is ranked 2,953
High RiskStock is 3.94x as volatile as Nifty

How to use scorecard? Learn more

Health CarePharmaceuticals
SmallcapWith a market cap of ₹111 cr, stock is ranked 2,953
High RiskStock is 3.94x as volatile as Nifty

Key Metrics

No LabelNo LabelPB RatioPB RatioDividend YieldDiv. Yield
-6.161.27
Sector PESector PESector PBSector PBSector Div YldSctr Div Yld
51.926.630.50%

Forecast & Ratings

Detailed Forecast 
Forecast data is currently unavailable for this stock

Price

Price Upside

Earnings

Earnings Growth

Revenue

Rev. Growth

See Detailed Forecast

Company Profile

Bharat Immunologicals and Biologicals Corporation Limited is a biotechnology company that manufactures and produces a range of pharmaceuticals products.

Get more out of Tickertape, Go Pro!

Customise key metrics, see detailed forecasts, download stock data and more

Forecasts

Price

Revenue

Earnings

Income

Balance Sheet

Cash Flow

Income Statement

Loading...

Financial YearFY 2015FY 2016FY 2017FY 2018FY 2019FY 2020FY 2021FY 2022FY 2023TTM
Total Revenue146.95129.42125.3736.1987.8768.0287.0179.4947.418.51
Raw Materialssubtract114.44112.9370.7226.9792.7974.3067.7464.9335.7125.40
Power & Fuel Costsubtract2.212.231.661.241.741.851.551.691.35
Employee Costsubtract9.6110.0310.2110.319.7811.3714.4413.8515.32
Selling & Administrative Expensessubtract2.202.428.810.960.450.650.600.731.05
Operating & Other expensessubtract14.354.4419.963.24-11.79-10.9421.872.169.64
Depreciation/Amortizationsubtract0.910.650.580.410.280.240.240.210.150.19
Interest & Other Itemssubtract1.135.694.211.012.004.754.795.607.057.54
Taxes & Other Itemssubtract0.55-2.752.71-3.70-1.58-3.99-6.10-0.93-5.79-6.56
EPS0.36-1.441.51-0.98-1.34-2.36-4.20-2.03-3.95-4.18
DPS0.000.000.000.000.000.000.000.000.000.00
Payout ratio0.000.000.000.000.000.000.000.000.000.00

Company Updates

Annual Report and Investor Presentation updates mentioned here are as reported by the company to the exchange

Peers & Comparison

Comparing 3 stocks from 
Health CarePharmaceuticals

Loading...

StockPE RatioPE RatioPB RatioPB RatioDiv. YieldDividend Yield
Bharat Immunologicals and Biologicals Corporation Ltd-6.521.27
Sun Pharmaceutical Industries Ltd45.796.530.74%
Cipla Ltd31.234.800.82%
Mankind Pharma Ltd57.5711.50

Price Comparison

Compare BIBCL with any stock or ETF
Compare BIBCL with any stock or ETF
BIBCL
Loading...

Shareholdings

Promoter Holdings Trend

Total Promoter Holding

Increasing promoter holding is considered good and reflects management’s positive view about the future outlook

In last 6 months, promoter holding in the company has almost stayed constant

Low Pledged Promoter Holding

Lower pledged promoter holdings is considered better

Pledged promoter holdings is insignificant

Institutional Holdings Trend

Total Retail Holding

Increasing retail holding can be considered bad as it can reflect that institutions and promoters are selling their stake which is being absorbed by retail investors.

In last 3 months, retail holding in the company has almost stayed constant

Foreign Institutional Holding

Foreign Institutional Holding is quantum of stock held by foreign large-quantities-trading entities. Increasing value indicates growing support and comfort for the stock

In last 3 months, foreign institutional holding of the company has almost stayed constant

Tickertape Separator

Shareholding Pattern

Retail and OthersForeign InstitutionsOther Domestic InstitutionsMutual FundsTotal Promoter Holding59.25%0.00%0.00%0.00%40.75%

Jun 2023

Sep 2023

Dec 2023

Mar 2024

Shareholding History

Dec '22MarJunSepDec '23Mar0.00%0.00%0.00%0.00%0.00%0.00%

Insider Trades & Bulk Deals

Hmm, looks like there hasn't been any net deal activity in the last 6 months

smallcases

Looks like this stock is not in any smallcase yet.

Events

Dividend Trend

No Dividends

Dividends are the portion of earnings that a company distributes to all its shareholders every year

BIBCL has not given any dividends in last 5 years

Dividends

Corp. Actions

Announcements

Legal Orders

Dividends

Hmm, looks like data is unavailable here. Please come back after some time
News & Opinions
Corporate
Bharat Immunological & Biolog.Corp. to hold board meeting

Bharat Immunological & Biolog.Corp. will hold a meeting of the Board of Directors of the Company on 16 August 2024.Powered by Capital Market - Live

2 months agoCapital Market - Live